GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bioretec Ltd (FRA:0TN) » Definitions » Ending Cash Position

Bioretec (FRA:0TN) Ending Cash Position : €6.29 Mil (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Bioretec Ending Cash Position?

Bioretec's Ending Cash Position for the quarter that ended in Dec. 2024 was €6.29 Mil.

Bioretec's quarterly Ending Cash Position declined from Dec. 2023 (€6.91 Mil) to Jun. 2024 (€3.95 Mil) but then increased from Jun. 2024 (€3.95 Mil) to Dec. 2024 (€6.29 Mil).

Bioretec's annual Ending Cash Position increased from Dec. 2022 (€1.22 Mil) to Dec. 2023 (€6.91 Mil) but then declined from Dec. 2023 (€6.91 Mil) to Dec. 2024 (€6.29 Mil).

Bioretec Ending Cash Position Historical Data

The historical data trend for Bioretec's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioretec Ending Cash Position Chart

Bioretec Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Ending Cash Position
Get a 7-Day Free Trial 2.27 6.62 1.22 6.91 6.29

Bioretec Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.22 9.20 6.91 3.95 6.29

Bioretec Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Bioretec's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=6.911+-0.622
=6.29

Bioretec's Ending Cash Position for the quarter that ended in Dec. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=3.949+2.34
=6.29

Bioretec Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Bioretec's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Bioretec Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bioretec Ltd (FRA:0TN) » Definitions » Ending Cash Position
Comparable Companies
OHEL:NXTMH OHEL:MODU OHEL:BONEH ABT BSX SYK MDT XTER:SHL EW SZSE:300760 DXCM XAMS:PHIA STE ZBH PODD XSWX:SOON SHSE:688271 TSE:7733 TSE:6869 LSE:SN.
Traded in Other Exchanges
BRETEC:Finland
Address
Yrittajankulma 5, Tampere, FIN, FI-33710
Website
https://www.bioretec.com
Bioretec Ltd is a medical device company focusing on the development of safe, and reliable bioabsorbable and bioresorbable implants for pediatric and adult orthopedics. The company's products are used world wide and continue to further develop materials and products for high-load-bearing clinical applications. Some of its brands include RemeOs, Activa IM-N, ActivaPi, and ActivaScrew.

Bioretec Headlines

No Headlines